/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Champions Oncology Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$6.03 -0.0109(-1.09%) CSBR at 04 Dec 2025 04:29 PM Biotechnology
Lowest Today 6
Highest Today 6
Today’s Open 6
Prev. Close 6.056
52 Week High 11.99
52 Week Low 4.16
Day’s Range: Low 6 High 6
52-Week Range: Low 4.16 High 11.99
1 day return -
1 Week return -
1 month return -9.49
3 month return -9.49
6 month return -4.83
1 year return +39.26
3 year return -6.36
5 year return -42.61
10 year return -

Institutional Holdings

Battery Management Corp 17.56

NEA Management Company, LLC 12.43

Tocqueville Asset Management L.P. 2.90

Vanguard Group Inc 2.37

Vanguard Total Stock Mkt Idx Inv 1.67

Renaissance Technologies Corp 1.10

BlackRock Inc 0.84

Morgan Stanley - Brokerage Accounts 0.64

Geode Capital Management, LLC 0.54

Millennium Management LLC 0.48

Vanguard Institutional Extnd Mkt Idx Tr 0.46

Northern Trust Corp 0.39

Acadian Asset Management LLC 0.29

HighTower Advisors, LLC 0.26

Susquehanna International Group, LLP 0.25

Fidelity Extended Market Index 0.23

Bank of New York Mellon Corp 0.19

State Street Corp 0.19

Bank of America Corp 0.18

Hillsdale Investment Management Inc. 0.18

Jane Street Group LLC 0.17

Dimensional Fund Advisors, Inc. 0.16

iShares Micro-Cap ETF 0.15

O'Shaughnessy Asset Management LLC 0.13

Fidelity Total Market Index 0.09

Fidelity Nasdaq Composite Index 0.08

Extended Equity Market Fund K 0.08

Fidelity Series Total Market Index 0.06

Spartan Extended Market Index Pool F 0.05

Schwab Total Stock Market Index 0.05

Northern Trust Extended Eq Market Idx 0.05

NT Ext Equity Mkt Idx Fd - L 0.05

Vanguard Instl Ttl Stk Mkt Idx InstlPls 0.05

NT Ext Equity Mkt Idx Fd - NL 0.04

Northern Small Cap Core I 0.04

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.03

Spartan Total Market Index Pool G 0.03

State St US Extended Mkt Indx NL Cl C 0.02

NT Quality SCC US Fund - L 0.02

NT Quality Small Cap Core 0.02

Market Status

Strong Buy: 1

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 83.50 M

PB Ratio 23.5834

PE Ratio 28.8381

Enterprise Value 78.16 M

Total Assets 32.34 M

Volume 10347

Company Financials

Annual Revenue FY25:56944000 56.9M, FY24:50155000 50.2M, FY23:53870000 53.9M, FY22:49109000 49.1M, FY21:41040000 41.0M

Annual Profit FY25:28555000 28.6M, FY24:20754000 20.8M, FY23:24338000 24.3M, FY22:25477000 25.5M, FY21:19566000 19.6M

Annual Net worth FY25:4701000 4.7M, FY24:-7276000 -7.3M, FY23:-5335000 -5.3M, FY22:548000 0.5M, FY21:334000 0.3M

Quarterly Revenue Q3/2025:13995000 14.0M, Q2/2025:12355000 12.4M, Q1/2025:17039000 17.0M, Q4/2024:13489000 13.5M, Q3/2024:14061000 14.1M

Quarterly Profit Q3/2025:-7995000 -8.0M, Q2/2025:5084000 5.1M, Q1/2025:10422000 10.4M, Q4/2024:6417000 6.4M, Q3/2024:6989000 7.0M

Quarterly Net worth Q3/2025:-466000 -0.5M, Q2/2025:-1834000 -1.8M, Q1/2025:4495000 4.5M, Q4/2024:728000 0.7M, Q3/2024:1313000 1.3M

Fund house & investment objective

Company Information Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Organisation Biotechnology

Employees 213

Industry Biotechnology

CEO Mr. Robert Brainin

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow